Fifth Third Bancorp
SIOX

Fifth Third Bancorp’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Fifth Third Bancorp’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-125
Closed -$54 – 2857
2022
Q4 		$54 Hold
125
– – ﹤0.01% 2641
2022
Q3 		$0 Hold
125
– – ﹤0.01% 2790
2022
Q2 		$0 Hold
125
– – ﹤0.01% 2833
2022
Q1 		$0 Hold
125
– – ﹤0.01% 2825
2021
Q4 		$0 Hold
125
– – ﹤0.01% 2822
2021
Q3 		$0 Hold
125
– – ﹤0.01% 2780
2021
Q2 		$0 Hold
125
– – ﹤0.01% 2565
2021
Q1 		$0 Hold
125
– – ﹤0.01% 2517
2020
Q4 		$0 Hold
125
– – ﹤0.01% 2483
2020
Q3 		$1K Hold
125
– – ﹤0.01% 2247
2020
Q2 		$0 Hold
125
– – ﹤0.01% 2286
2020
Q1 		$0 Hold
125
– – ﹤0.01% 2344
2019
Q4 		$1K Hold
125
– – ﹤0.01% 2177
2019
Q3 		$1K Hold
125
– – ﹤0.01% 2137
2019
Q2 		$1K Hold
125
– – ﹤0.01% 2230
2019
Q1 		$1K Hold
125
– – ﹤0.01% 2122
2018
Q4 		$1K Sell
125
-1,250
-91% -$18K ﹤0.01% 2193
2018
Q3 		$27K Hold
1,375
– – ﹤0.01% 1530
2018
Q2 		$25K Buy
1,375
+1,250
+1,000% +$18.4K ﹤0.01% 1592
2018
Q1 		$1K Hold
125
– – ﹤0.01% 2261
2017
Q4 		$5K Hold
125
– – ﹤0.01% 2014
2017
Q3 		$7K Hold
125
– – ﹤0.01% 1877
2017
Q2 		$23K Hold
125
– – ﹤0.01% 1518
2017
Q1 		$15K Hold
125
– – ﹤0.01% 1629
2016
Q4 		$12K Hold
125
– – ﹤0.01% 1761
2016
Q3 		$14K Hold
125
– – ﹤0.01% 1746
2016
Q2 		$13K Buy
+125
New +$12.5K ﹤0.01% 1721

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Fifth Third Bancorp's SIOX Position: Q1 2023 in Review

Fifth Third Bancorp sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 125 shares — an estimated $54 sold.

Fifth Third Bancorp first reported a position in SIOX in Q2 2016 and held it in 27 quarters. The position peaked at $27K in Q3 2018. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Fifth Third Bancorp reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Fifth Third Bancorp sold 125 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $54.
  • Fifth Third Bancorp first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2016 and held it in 27 quarters.
  • Fifth Third Bancorp's Sio Gene Therapies Inc. Common Stock position peaked at $27K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Fifth Third Bancorp's 13F filing for Q1 2023, filed 24 Apr 2023.